Orange S.A. (EPA:ORA)

Revance Therapeutics Revenue

Orange had revenue of 19.85B EUR in the half year ending June 30, 2025, with 2.59% growth. This brings the company's revenue in the last twelve months to 40.27B, up 0.27% year-over-year. In the year 2024, Orange had annual revenue of 40.26B with 1.47% growth.

• Revenue (ttm): 40.27B
• Revenue Growth: +0.27%
• P/S Ratio: 0.91
• Revenue / Employee: 317.35K
• Employees: 126,909
• Market Cap: 36.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	40.26B	582.00M	1.47%
Dec 31, 2023	39.68B	551.00M	1.41%
Dec 31, 2022	39.13B	-3.40B	-7.98%
Dec 31, 2021	42.52B	252.00M	0.60%
Dec 31, 2020	42.27B	32.00M	0.08%